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Precise, comprehensive imaging of the arterial circulation is the cornerstone of successful revascularization of the ischemic
extremity in patients with diabetes mellitus. Arterial imaging is challenging in these patients because the disease is often
multisegmental with a predilection for the distal tibial and peroneal arteries. Occlusive lesions and the arterial wall itself
are often calcified and patients presenting with ischemic complications frequently have underlying renal insufficiency.
Intra-arterial digital subtraction angiography (DSA), contrast enhanced magnetic resonance angiography (MRA), and
more recently, computerized tomographic angiography (CTA) have been used as imaging modalities in lower extremity
ischemia. Each has specific advantages and shortcomings in this patient population, which will be summarized and
contrasted in this review. DSA is an invasive technique most often performed from a femoral arterial puncture and
requires the injection of arterial contrast, which can occasionally cause allergic reactions. In patients with pre-existing
renal insufficiency, contrast infusion can result in worsening renal failure; although usually self-limited, it may
occasionally require hemodialysis, especially in patients with diabetes. However, DSA provides the highest degree of
spatial resolution and image quality. It is also the only modality in which the diagnosis and treatment of arterial disease
can be performed simultaneously. MRA is noninvasive, and when enhanced with gadolinium contrast injection provides
arterial images of comparable quality to DSA and in some circumstances may uncover distal arterial targets not visualized
on DSA. However, spatial resolution is inferior to DSA and erroneous interpretations due to acquisition artifacts are
common. Specialized equipment and imaging techniques are necessary to minimize their occurrence in the distal lower
extremity. In addition, due to the risk of inducing nephrogenic systemic fibrosis, gadolinium-enhanced MRA cannot be
used in patients with renal insufficiency. CTA is noninvasive and rapidly performed, with better spatial resolution than
MRA, but requires the largest volume of contrast infusion, exposes patients to high-doses of radiation, and is subject to
interpretive error due to reconstruction artifacts especially in heavily calcified arteries, limiting its usefulness in many
patients with diabetes. For patients in whom the planned intervention is a surgical bypass, DSA and MRA will provide
high quality images of the lower extremity arterial anatomy. For patients in whom a catheter-based intervention is the
likely treatment, a diagnostic DSA immediately followed by a catheter-based treatment in the same procedure is the
preferred approach. In patients with pre-existing renal dysfunction, in which gadolinium-enhanced MRA is contraindi-
cated, DSA or CTA can be performed. However, patients should have an infusion of intravenous normal saline solution
or sodium bicarbonate before the procedure to reduce the incidence of contrast-induced nephropathy. (J Vasc Surg
2010;52:81S-91S.)Precise, comprehensive anatomic imaging is the cor-
nerstone of successful revascularization of the ischemic
lower extremity in patients with diabetes mellitus. Contrast
arteriography has been the mainstay for many years and
remains the gold standard due to its superior image resolu-
tion and being the only modality used for both diagnosis
and treatment. However, magnetic resonance angiography
(MRA),1-3 and more recently, computerized tomographic
angiography (CTA),4,5 have become viable alternatives due
to being inherently less invasive with image quality rivaling
digital subtraction angiography (DSA). Imaging of arterial
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presents unique challenges due to the distal location of the
occlusive lesions, most commonly involving the crural and
pedal arteries. Detailed imaging of these vessels is critical in
planning endovascular procedures or surgical bypass. The
presence of multisegment disease, the frequency of calcifi-
cation of both the atherosclerotic lesions and the wall of the
arteries involved, and the presence of renal insufficiency are
additional challenges often encountered. Consequently, all
three modalities have advantages and disadvantages in spe-
cific patients based on their clinical presentation and co-
morbidities.
Contrast arteriography. The use of cut-film radio-
graphs and rapid film changers has long given way to
intra-arterial DSA, the current standard for contrast arte-
riography of the lower extremity. DSA has especially im-
proved the imaging of diabetic arterial occlusive disease due
to its superior ability to visualize distal small caliber vessels
with less contrast. Currently available machines have com-
pletely automated sequences that set exposure values and
frame speed for the various arterial segments studied in the
abdomen, pelvis, and lower extremity. Improved computer
processing power and equipment design has made the
commonly used techniques such as subtraction, re-masking,
81S
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ple. Road-mapping and unsubtracted image referencing
(fluoro-save mode) used during catheter-directed interven-
tions are easily performed by the operator at the table.
Gantry angle, table position, collimation, magnification,
and edge filters are easily changed by the operator to
optimize imaging for any arterial segment.
Perhaps the most important improvement has been the
development of high-resolution flat panel image intensifiers
that have outstanding image quality and minimize parallax
distortion. The newest flat panels on fixed imaging systems
have a larger field of view (FOV) of 48 cm (19 inches)
which can cover larger areas of interest, translating into
fewer injections and radiation exposure. DSA imaging is
available on portable units, primarily used in the operating
room, or in a dedicated fixed-mount angiography suite.
More recently, hybrid operating rooms with fixed-
mount angiographic equipment have become available
making it possible to perform sophisticated, high quality
DSA in a surgical environment for hybrid procedures in-
volving the simultaneous performance of surgery and an-
giography such as endovascular aneurysm repair (Fig 1).
Gantries are usually ceiling-mounted in hybrid rooms and
can be moved away from the table during conventional
surgical procedures. Fixed-mount units have more power-
ful generators that provide detailed imaging with far supe-
rior image resolution 10 times that of portable systems. The
primary advantages of portable units are portability and
availability. They can be used in any operating suite and can
theoretically be moved to the location of the patient in
clinical circumstances when transportation to an angiogra-
phy suite is not possible. Portable systems are also far less
expensive. A mobile C-arm is usually less than $200,000,
while a high quality fixed-mount system in an angiography
Fig 1. A hybrid, endovascular operating suite. Note the anesthe-
sia equipment and ceiling mounted C-arm that can be moved away
from the table during surgery. The fluoroscopy table can be tilted
like a typical operating room table and has attachments for the
connection of self-retaining retractors.suite can cost between 1.5 and 3 million dollars. Manyvascular surgeons have had limited access to fixed systems
because they have traditionally been located in interven-
tional radiology or cardiology departments, making mobile
units in the operating room the only alternative available.
Although it is possible to perform virtually any diagnostic
or interventional procedure on portable units, the superior
capabilities of fixed-mount systems in a dedicated angiog-
raphy suite or hybrid operating room make them the ideal
and preferred location when available.
The principal disadvantages of DSA are complications
resulting from arterial access and the infusion of contrast
agents. Complications related to femoral access have de-
creased with the use of lower profile catheters and sheaths.
In most cases, diagnostic angiography can easily be per-
formed with a 4F sheath and compatible catheters, whereas
most lower extremity interventions can be performed with
a 5F or a 6F system. DSA is most commonly performed
from an ipsilateral or contralateral femoral puncture. The
author prefers the use of contralateral femoral puncture
with placement of a multi-side-hole flush catheter in the
infrarenal abdominal aorta to perform an aortoiliac injec-
tion followed by access of the contralateral distal external
iliac or proximal common femoral artery over the aortic
bifurcation to obtain images of the extremity in question.
In our practice, we routinely perform femoral puncture
guided by ultrasound scan imaging (Fig 2), which has
improved our ability to easily gain access in any patient
including those who are obese and without a palpable
femoral pulse. Ultrasound scan-guided punctures are espe-
cially useful for antegrade femoral approaches and for the
preclose technique in endovascular aneurysm repair. An
additional advantage is the ability to both clearly identify
the common femoral artery and direct the entry needle into
the “best” spot on the anterior wall of the artery. Since its
routine use in our procedures, ultrasound scan-guided
puncture has reduced our rate of access-related complica-
tions (unpublished data).
Contrast agents enhance the details of the arterial cir-
culation due to a radiodensity that is higher or lower than
surrounding tissues. Typical agents with a density higher
than soft tissues are iodine-containing compounds, which
are either ionic or nonionic. Nonionic agents have an
osmolality of 320 to 880 mosm compared to 1500 to 1700
mosm for ionic agents. Plasma has an osmolality of 285
mosm. Contrast agents can be delivered by power injection
or manually through a syringe or manifold depending on
the circumstances. Toxic side effects of contrast agents
result from their hyperosmolality. Common side effects
include nausea, vomiting, and pain in the area of the
arterial bed being studied. Pain is especially common in
the more distal arterial beds of the lower extremity and
may cause unintentional movement or twitching, result-
ing in image degradation. Nonionic agents with lower
osmolality cause less pain,6 hemodynamic instability,7 can
be diluted with little loss of image quality on fixed imaging
systems, and have largely replaced ionic contrast in our
practice. Allergic reactions due to the release of histamine
are another important side effect and most common with
common femoral artery (c).
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manifested by urticaria, although more severe reactions
including bronchospasm, laryngeal edema, and anaphylac-
tic shock leading to cardiopulmonary arrest can occur.10 In
patients with a history of contrast-induced allergic reac-
tions, premedication with oral methylprednisolone before
angiography alone can significantly reduce allergic reac-
tions11,12 along with the avoidance of ionic, high osmola-
lity agents.13
Nephrotoxicity is a particularly important concern in
patients with diabetes mellitus and underlying renal insuf-
ficiency. It is a common cause of acute renal failure in
hospitalized patients.14 Clinical manifestations can range
from a mild, reversible rise in serum creatinine levels to
renal failure requiring hemodialysis. Pre-existing renal dys-
function remains the most important risk factor for the
precipitation of contrast-induced nephropathy (CIN) in
patients15 and is independent of the type of contrast agent
used, either ionic or nonionic, and the volume infused,
although it occurs less frequently with low-osmolality
agents.16 The physiologic basis of contrast-induced ne-
phropathy seems to be transient local ischemia in the renal
tubule. It is postulated that as contrast material is filtered
without re-absorption, an osmotic pressure gradient is cre-
ated that results in increased intra-tubular pressure, afferent
arteriolar vasoconstriction, and a decrease in the glomerular
filtration rate. The decrease in glomerular filtration rate
results in regional tubular ischemia.17 There is a relation-
ship between the degree of renal insufficiency and the
likelihood of developing contrast-induced nephropathy.
Although it occurs in only 1% to 2% in patients with normal
renal function, it increases to 10% in patients with serum
creatinine levels between 1.3 and 1.9 mg/dL and to 62% in
patients with levels greater than 2 mg/dL.15,18
Although diabetes itself is not considered an indepen-
dent risk factor for the occurrence of CIN, the incidence is
higher in patients with diabetes presumably due to the
higher incidence of subclinical renal insufficiency. Patients
with type 1 diabetes are more susceptible than those with
type 2 diabetes. Patients with diabetes are also more likely
to require hemodialysis from CIN.19-22 Special care should
be taken in patients undergoing arteriography while taking
dimethylbiguanide (Metformin), an oral hypoglycemic
agent. Metformin use in the presence of renal dysfunction
can result in lactic acidosis in patients developing contrast-
induced nephropathy. It has been recommended that the
patients terminate the use of Metformin for 48 hours
before and after contrast angiography.23
The prevention of CIN has been studied extensively.
Increasing the transit time of contrast through the renal
tubule by inducing a brisk diuresis is the goal of therapy.
Currently, intravenous hydration is the most effective pre-
ventive measure using 0.9% normal saline solution or alter-
natively intravenous sodium bicarbonate administered for 4
hours before contrast exposure.24-26 The use of diuretics
such as furosemide and mannitol has not been effective andFig 2. Ultrasound scan-guided femoral arterial access is per-
formed by one operator. In this example, the right hand controls
the ultrasound probe (a) to image the common femoral artery just
proximal to the femoral bifurcation (b). The left hand punctures
the artery with the access needle, which can be seen as it enters themay be deleterious.25 The antioxidant N-acetylcysteine
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before and after the procedure may also be protective.27
Carbon dioxide (Co2)
28 and gadolinium have been
used in place of conventional contrast in patients with renal
insufficiency or a history of severe allergic reactions. CO2 is
non-toxic when injected into the arterial circulation and is
visible due to a radiodensity that is substantially lower than
the surrounding soft tissues. It requires some additional
equipment for automated infusion and images must be
acquired at a higher frame rate due to the rapidity with
which it dissipates. In the past, images obtained were of
poor quality and it was rarely used for diagnostic imaging in
the extremities. With the superior imaging and postpro-
cessing capabilities of modern equipment, it has proven to
be very useful especially in patients with compromised renal
function.29 Image quality of the aortoiliac segment is quite
good with CO2 angiography but degrades significantly in
the smaller caliber arteries of the distal lower extremities,
especially with diffuse disease. The inability to completely
fill the lumen of distal small arteries leads to overestimation
of the degree of stenosis.30 Consequently, a commonly
used imaging strategy in our practice is to use CO2 for
imaging the aortoiliac segment and switch to conventional
contrast for the extremities in diabetic patients with com-
promised renal function.
Another alternative to conventional contrast with bet-
ter opacification of vessels than CO2 for patients with renal
insufficiency is the intra-arterial injection of gadolinium
agents usually used in MRA as an off-label use. However,
this technique has largely been abandoned due to nephro-
genic systemic fibrosis.
In patients with renal insufficiency, contrast exposure
can be decreased by studying only the extremity when the
femoral pulse is normal or by using CO2 for the aorta and
pelvis. Additionally, it has been our practice to dilute full
strength contrast to a 50% concentration with normal saline
solution so as to further reduce the amount infused. For
patients with extensive tibial and peroneal disease and a
patent superficial femoral artery, catheter advancement into
the distal superficial femoral or popliteal artery improves
imaging of the distal tibial and pedal vessels with less
contrast than is required from a more proximal injection in
the external iliac artery.
The imaging technique used can have a significant
effect on the resolution and opacification of the distal tibial
and pedal arteries. Having a patient who is immobile,
comfortable, cooperative, and proper positioning of the
extremity and imaging equipment is critical to maximize
information, especially in the distal lower extremity. Many
surgeons study the lower extremity by a single injection
from the aorta using bolus chase or stepping technique.
Fixed-mount systems come with imaging software that
automates the sequence making it simple and fast to per-
form and it can be used to study both limbs simultaneously.
However, in patients with diabetes with extensive multiseg-
ment disease or slow transit times, image acquisition can
take more than 2 minutes to complete.31 Limiting move-
ment is critical to maximize image quality, which may beimpossible for even the most cooperative patient during
long acquisition times resulting in poor resolution, espe-
cially of tibial and pedal vessels. For many years, our pref-
erence in the diabetic extremity has been selective single
field static imaging as described by Gates and Hartnell.31
For each station, the patient and C-arm can be positioned
to optimize imaging while choosing appropriate collima-
tion, magnification, and time delays.
Complete imaging of the infrageniculate arteries re-
quires two planes of view, the most important being ori-
ented perpendicular to the interosseous membrane to sep-
arate the anterior tibial and peroneal arteries in the lower
leg and tarsal and plantar vessels in the foot. In some
circumstances, catheter advancement to the distal superfi-
cial or popliteal arteries may be necessary (Fig 3). Use of
this technique produces high quality images in most pa-
tients, even those with diffuse tibial-peroneal disease. Ad-
ditionally, single field imaging uses less contrast. A typical
bolus-chase study can require 80 to 100mL of full-strength
contrast, while selective single field imaging of the extrem-
ity can be performed in sequential fashion using hand
injection or power injection with dilute contrast at signifi-
cantly smaller volumes (40-45 cc with an aortic run, 25-30
cc without an aortic run).
Computed tomographic angiography. The devel-
opment of the slip-ring gantry led to the development of
spiral CT scanning, which for the first time permitted the
continuous linear motion of the patient through a gantry
containing the radiograph emitter and detector rows con-
tinuously sweeping over a 360° arc. Data are acquired
rapidly over a continuous volume (the Z axis) rather than as
a number of discontinuous single slices. Because the data
are collected over a continuous volume, axial slices can be
reconstructed from the digital data set at very small intervals
without requiring additional radiation exposure. More re-
cently, the development of multi-detector CT scanners has
made it possible for CT scanners to capture multiple sepa-
rate slices per 360° rotations. Slices can be acquired at 1
mm or even submillimeter thickness with rotation time in
the range of 0.3 seconds. Complete imaging of the abdom-
inal vasculature can be accomplished in a fraction of the
time of previous generation scanners while improving im-
age resolution and decreasing artifacts. Advances in both
hardware and computer software technology have im-
proved the graphic image display despite the reduction in
scan time.
Current scanners typically generate a 512 512matrix
or, if needed, 1024  1024 matrix. Each data point in the
matrix is mapped to a gray scale for display. Both the size of
the matrix and FOV has a direct impact on the resolution of
the display. Data points depicted as a two-dimensional
image are known as a pixel (picture element). However,
because the data are actually acquired in three-dimensions
in spiral CT, each data point actually represents a three-
dimensional image known as a voxel (volume element).
The size of each voxel is determined by the FOV and the
thickness of the radiograph beam. Current generation CT
scanners displaying images in a 512 512 or greater matrix
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approximately twice the resolution of a typical magnetic
resonance imaging (MRI).
Improvements in resolution and acquisition time with
multi-detector spiral scanners made CTA possible.32 As
with conventional arteriography, the administration of
contrast allows a differentiation of the similar densities of
blood and soft tissues. Because contrast generally flows
rapidly through the blood stream, CT acquisition must
occur rapidly, “chasing” the bolus of contrast over a rela-
tively long distance, only made possible by the fast scanning
capabilities of current scanners. Timing of the initiation of
image acquisition is crucial in that the contrast volume
must reach its maximum intensity in the area of interest as
acquisitions are being obtained. Dedicated computer algo-
rithms have been developed by CT scanner manufacturers
to make this possible. All are based on a stationary contin-
Fig 3. Foot arteriogram of a woman with toe gangrene
artery with a superficial femoral artery occlusion, the foot
bypass surgery or an intervention. After angioplasty an
repositioned in the proximal popliteal artery. The dorsa
(b) and anterior/posterior views (c).uous scan of a single slice in which contrast density ismeasured in the area of interest, usually a large vessel like
the proximal abdominal aorta, and CT acquisition is trig-
gered automatically once the machine senses that the con-
trast volume has reached an appropriate concentration at
that slice. Multiple factors beyond the scope of this discus-
sion, such as KVP (tube voltage) and MA (radiation dose/
second), collimation, table feed and pitch, patient position-
ing, and contrast injection parameters can be manipulated
during the pre-scan process along with post-scan parame-
ters such as increment slice within the FOV, windowing,
and a variety of reconstruction algorithms to provide high
quality images of the arterial anatomy in both the abdomen
and lower extremity rivaling those of conventional angiog-
raphy.33
Protocols based on a series of settings of these param-
eters, along with specific technician and patient instruc-
tions, have been developed to generate a set of images that
In a contrast injection performed from the external iliac
es are not visualized suggesting a poor situation for either
ting of the superficial femoral artery, the catheter was
is artery and arch vessels are now clearly seen in lateral: (a)
arteri
d sten
lis pedis optimal for any specific anatomic area of interest. The
fied p
JOURNAL OF VASCULAR SURGERY
September Supplement 201086S Pomposellidata set can be reconstructed in a variety of ways includ-
ing axial images, maximum intensity projections (MIPs)
that resemble conventional angiograms, and detailed
two-dimensional sagittal and coronal views. Striking
three-dimensional surface shaded displays of the vascu-
lature often portrayed in color, can be rotated to interpret
the area in question from any point of view.When viewed in
its entirety, the portfolio of reformatted images from aCTA
provides the vascular surgeon with an unrivaled ability to
understand completely the anatomic features of any blood
vessel being studied.
Although CTA has in many cases become a preferred
imaging modality for many vascular surgeons, it does
have shortcomings which must be recognized. All of the
images depicted in standard CTA protocol are “artificial”
reconstructions and are, therefore, subject to potential
reconstruction-based artifacts. These include partial vol-
ume effects, beam hardening artifacts, motion artifacts,
and volume averaging artifacts, which are particularly
troublesome when imaging calcified plaques within arte-
rial structures. Stair-step artifacts occur when the recon-
struction interval on a spiral CT is too large giving the
vessels step-like appearance, which can give the erroneous
impression of an area of stenosis. Window level setting
errors affect the ability to differentiate calcium in the plaque
or arterial wall from contrast (Fig 4). Setting a window level
too narrowly results in a significant increase in visible noise
that will degrade the visualization of fine structural details,
whereas a window that is too wide will abolish small differ-
ences in contrast.33 Adjusting the window setting to differ-
entiate calcification from contrast is perhaps the most im-
portant concept to understand when evaluating occlusive
lesions in a CTA, although in some cases, especially in small
Fig 4. Axial images of a computed tomography (CT) a
portion of the anterior tibial artery (within the boxes). In
brightness makes it impossible to differentiate calcium fro
is occluded. In the image on the right, after decreasing th
with contrast visible within the lumen adjacent to a calciheavily calcified arteries so commonly encountered in theischemic diabetic extremity, it may be impossible to deter-
mine the difference between a calcified stenosis and total
occlusion. This phenomenon is especially evident when
viewing MIPs, which display calcified plaque and metallic
stents prominently.34 Reconstructions using multipath
curved planar reformatting have been developed to over-
come this problem (Fig 5). For patients with advanced
multi-segment disease or slow transit times, image acquisi-
tion may out run the contrast bolus requiring a second
acquisition sequence in reverse.
Two additional problems with CTA are the high-
radiation dose, particularly when multiple CT scans are
being performed over a relatively short period of time,35
and the large volumes of contrast that are necessary, up-
ward of 150 to 180 cc, with full-strength nonionic contrast
for a single CTA run.36 The latter issue may be especially
problematic if the patient is facing a catheter-based inter-
vention requiring further contrast infusion.
Magnetic resonance angiography. MRI uses three
types of applied external magnetic fields singly or in com-
bination to produce signals inside the patient that are
converted into images. The external magnetic field magne-
tizes the subject causing protons within the subject to line
up in parallel with the external field. The physical charac-
teristics of the protons and the size of the external magnetic
field determine the resonance frequency of the proton.
Field gradients alter the uniform magnetic field in any of
three different directions causing the protons to alter their
resonance frequency according to the magnetic field gradi-
ent’s position. Resonant coils placed adjacent to the area
being studied, such as the leg or foot, produce the radio-
frequency (RF), which is tuned to the resonance frequency
of the protons. The applied RF along with the gradients
ram of the distal lower extremity through the proximal
age on the left, setting the window level with too much
ntrast giving the appearance that the anterior tibial artery
htness, the anterior tibial artery can be seen to be patent
laque.ngiog
the im
m co
e brigmanipulates the protons to generate a signal detected by
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tuned to a specific frequency on the dial. This signal is
amplified, digitized, and processed to produce the image.
The strength of the magnetic field determines the speed of
image acquisition and its resolution. For an MRA a field
strength of 1.5 or 3 tesla is used.
The contrast in MR images depends on the character-
istics of the object being imaged and on the specifics of the
sequence chosen. Images are typically referred to as either
T1-weighted or T2-weighted images. T2-weighted images
display simple fluids as bright and other tissues as black. An
MRA is performed with T1-weighted image sequences.
Objects that are bright on T1-weighted images include fat,
methemoglobin, flow effects, and MRI contrast agents. A
Fig 5. Maximum intensity projections (MIPs) of an anterior tibial
artery displays calcium and stents brightly and can obscure luminal
detail making it impossible to determine if the artery is patent (a).
With the use of curved planar reformatting, the image of the
anterior tibial artery can be reconstructed repeatedly as it is rotated
along the center line of the artery allowing visualization of many
different points of view (b). The same arterial segment recon-
structed from a different perspective demonstrates that the artery is
patent.combination of RF and gradients can be used to create animage in MRI, known as MR pulse sequencing, character-
ized as spin echo or gradient echo sequences. Gradient
echo sequences are used to create T1-weighted images seen
in an MRA. All pulse sequences have fundamental param-
eters known as echo time (TE) and repetition time (TR)
that determine image contrast. T2-weighted images have a
longer TE and TR. Because of this, these sequences are
slower and not appropriate for contrast-enhanced MRA.
T1-weighted images have very short TR and TE, which is
most appropriate for most angiographic examinations. As
with CTAs, MR image sequences include the FOV and
image matrix. For two-dimensional images, the FOV may
be 40  30 cm with a slice thickness of 5 mm with
resolution determined by the number of pixels within the
FOV, which is determined by image matrix. Most MRAs,
however, are performed with three-dimensional imaging.
In this case, the FOV is measured in three dimensions
(voxel) such as 40 30 30 with the corresponding voxel
size determined by the matrix.37
An MRA can be performed either without contrast or
with contrast-enhanced techniques. Because of superior
image resolution, contrast-enhanced MR has generally re-
placed non-contrast techniques for imaging of the distal
lower extremity arterial circulation, most relevant to the
current discussion.38-40 However, the recent description of
the nephrogenic systemic fibrosis (NSF)41 in patients re-
ceiving gadolinium contrast agents has limited its utility in
patients with diabetes with compromised renal function
(see below).The most common non-contrast-enhanced
MR technique used is time of flight (TOF angiography).
TOF uses a rapid T1-weighted pulse sequence in either
sequentially acquired two-dimensional slices or a three-
dimensional imaging slab. In a single slice image, when the
data are gathered rapidly, the protons within the slice lose
much of their magnetization resulting in less signals from
these protons and the tissues within the slice are not well
seen. When fully magnetized protons in a vessel flow into
the slice of interest, they produce much greater signals than
the surrounding tissue resulting in a white image, which is
very bright with the surrounding tissues being relatively
dark. Special RF pulses can be applied to the tissue either
above or below the slice to eliminate magnetization from
that tissue. If an inferior saturation pulse was used in an
axial image, only the protons flowing into the slab from the
arterial vessels above the slice would be bright and the veins
would be eliminated. The series of such images obtained
would produce two-dimensional TOF abdominal angio-
gram. Newer non-contrast techniques include steady state
free precession,42 arterial spin labeling,43 and half-Fourier
fast spin echo imaging44 with flow spoiled gradients. All of
these techniques are combinations of several different
methods designed to accentuate the signal from flowing
blood and attenuate that from non-moving structures and
tissues with signal characteristics different from blood.
Contrast-enhanced MR angiography (CMRA) uses an
agent comprised of the rare element gadolinium chelated
with another substance to avoid the release of free gadolin-
ium, which is toxic, into the body. Two common agents
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(Gd-BOPTA). CMRA is usually performed as a three-
dimensional imaging sequence. Three-dimensional sequences
are typically faster and of higher resolution than non-
contrast enhanced angiograms and provide a similar level of
coverage. In a sense, describing gadolinium as contrast is
incorrect because it is not actually “seen” on the image but
shortens the T1 of the protons in the vicinity making them
more conspicuous on T1-weighted imaging. Like CTA
angiography, CMRA involves imaging a large volume over
a long distance. Obtaining images with adequate spatial
resolution requires a long acquisition time and is adversely
effected by the patient’s motion or breathing. Moreover, as
with CTA contrast, intravenously administered gadolinium
flows into the studied volume in a time-dependent fashion
based on cardiac output and the severity and extent of
proximal occlusive lesions. If image acquisition occurs be-
fore the contrast reaches the area of interest, not all vessels
in the region will be optimally enhanced, and if obtained
too late it will be “contaminated” by contrast enhancement
of the adjacent veins.
The quality of images as a function of contrast timing to
image acquisition is referred to as temporal resolution.
Optimizing spatial and temporal resolution in CMRA of
the extremity requires a step table technique that divides
the volume of interest into four stations, abdomen/pelvis,
thighs, calves, and feet. Maximizing image quality in the
lower leg and the foot requires a set of specialized coils to
improve the signal-to-noise ratios and specialized software
to control the table movement. Venous contamination is a
common problem in the more distal stations when using
the step table technique, although methods have been
developed to minimize it. Similar to CTA, the data set of a
contrast-enhanced three-dimensional MRA can be recon-
structed in a variety of ways to create images from multiple
perspectives to optimize visualization of the anatomy. The
most commonly used algorithm is the MIP, which resem-
bles a conventional arteriogram.
Recently, a rare condition known as NSF, previously
described as nephrogenic fibrosing dermopathy, has been
reported in patients receiving gadolinium contrast agents in
the presence of chronic renal failure.41 NSF is characterized
by skin thickening and hyperpigmentation of the extremi-
ties and the trunk, somewhat analogous to scleroderma. In
patients with more severe involvement, contractures, organ
fibrosis, and death have been reported. All reported cases
have occurred in patients with renal insufficiency, primarily
those with very poor kidney function in the setting of
chronic renal failure, although it has been occasionally
reported in acute renal failure as well. There is no specific
treatment other than attempting to improve renal function.
Steroids and other anti-inflammatory treatments have been
used along with hemodialysis and photopheresis.45 The
association between NSF and gadolinium-containing con-
trast agents was reported in 2006 in a cohort of patients on
dialysis undergoing MRA.41 Since that time, there have
been hundreds of reported cases in patients both receiving
dialysis and not.46 There seems to be a dose-dependentresponse with the disease more commonly occurring in
patients receiving larger doses of gadolinium contrast
agents or undergoing repeated studies. Gadolinium agents
are generally cleared rapidly by the kidneys with normal
renal function but the clearance time may be increased
100-fold in those with severe renal insufficiency. To date,
no cases of NSF have been reported in patients receiving
gadolinium agents with normal renal function. The major-
ity of cases have occurred with the use of Gadodiamide
(Omniscan, GE Healthcare, Piscataway, NJ) with smaller
numbers associated with Gadobenate Dimeglumine (Mag-
nevist, Bayer HealthCare Pharmaceuticals, Berlin, Ger-
many), and Gadoversetamide (OptiMARK, Covidien Im-
aging Solutions, Hazelwood, Mo). Omniscan has the
weakest binding of gadolinium ions to the chelating agent,
which may explain its higher incidence of NSF, thought to
occur as a reaction to free gadolinium ions. Based on the
reported observations of NSF with these agents, the use of
gadolinium contrast agents is now contraindicated in pa-
tients with a glomerular filtration rate of less than 30
mL/minute or acute renal insufficiency.
The technique for CMRA of the distal arterial circula-
tion in patients with diabetes requires a system with the
fastest and strongest gradients available. This results in
faster acquisition times with higher degrees of spatial reso-
lution and improved signal-to-noise ratios. As described
previously, the use of dedicated coils for specific vascular
beds are useful especially for imaging the distal pedal and
foot circulation. When administering contrast, a dual-
chamber power injector is best for rapid administration of
contrast followed by a “saline chaser” which decreases the
amount of contrast used. One disadvantage is the powerful
magnetic field, which requires specialized patient monitor-
ing equipment, which can be troublesome in critically ill
patients. Specialized software is needed to enable step table
and parallel imaging. Venous contamination can be dimin-
ished in CMRA by the use of special blood pressure cuffs
placed around the extremity. Postprocessing can be com-
plex and requires specialized workstations. Although MIP
images are favored by vascular surgeons because they re-
semble angiograms, like CTA images, they are artificial
constructs and subject to reconstruction artifacts. Correct
interpretation of MRA imaging requires review of both
source images and maximum intensity projections and for
most surgeons is best done with a radiologist.
Imaging strategies. Diagnostic imaging is a misno-
mer. For the experienced vascular specialist, the diagnosis
of lower extremity ischemia should be straightforward in
most cases, based on a careful history and physical exami-
nation augmented by noninvasive studies. For the most
part, anatomic imaging should be considered strategic –
only performed once a clinical decision has been made to
intervene due to the presenting symptoms and physical
findings. In the past, choosing the optimal anatomic imag-
ing study was a trade-off balancing the superior image
quality provided by DSA at the expense of being invasive
with the attendant complications previously outlined.
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The development of MRA and especially contrast-
enhanced three-dimensional MRA38,39 provided an alter-
native that was noninvasive, cost-effective,47 with imaging
capabilities equal to or superior to DSA.48 Comparing the
diagnostic utility and accuracy of MRA and DSA has been
the subject of numerous studies over many years. In early
studies, MRA andDSAwere in agreement in 80% to 85% of
the time, although DSA was clearly superior for imaging
very distal arteries, especially pedal vessels. With the devel-
opment of contrast-enhancedMRA, three-dimensional im-
aging techniques, and specific coils for the distal leg and
foot, more recent studies have demonstrated the superior-
ity ofMRA in imaging very distal crural and pedal arteries in
comparison to DSA,49,50 in addition to being less invasive
and more cost-effective. One disadvantage was the rela-
tively long acquisition times resulting in timing sequence
errors in contrast acquisition, venous contamination, and
the inability to image multiple vessels simultaneously with
different rates of blood flow without additional contrast
injections. Many of these shortcomings have been over-
come with time-resolved imaging of contrast kinetics
(TRICKS)51 MRA and the use of newer three tesla mag-
nets which permit more rapid sequencing with a higher
degree of spatial and temporal resolution.1
It is important to recognize that many studies fail to
adequately describe the specifics of their angiographic tech-
nique, which can greatly affect the results of DSA. Specifi-
cally, the use of bolus-chase arteriography, injection of
inadequate volume of contrast, or improper catheter posi-
tioning may result in inadequate filling of distal vessels and
an erroneous interpretation (Fig 3). The recognition of
nephrogenic systemic fibrosis as a potentially fatal compli-
cation of gadolinium contrast agents in patients with renal
insufficiency has resulted in the virtual abandonment of
contrast MRA in these patients. Moreover, the widespread
use of catheter-based interventions for treating lower ex-
tremity ischemia has led to a resurgence of interest in DSA
imaging. In many practices, including our own, an addi-
tional advantage is the efficiency and convenience of being
able to perform the intervention during the same procedure
as the diagnostic angiogram.
Although CTA can provide imaging which rivals the
quality of DSA or MRA, difficulties interpreting images in
areas of heavy calcification in distal target arteries and the
added contrast exposure are significant disadvantages
which limit its usefulness in the diabetic ischemic extremity.
In current practice, in which catheter-based interven-
tions have become a mainstay for treating lower extremity
ischemia, a clinical evaluation followed straight away by a
diagnostic arteriogram is probably the most efficient and
cost-effective approach in most patients requiring treat-
ment. If a treatable lesion is found, a catheter-based inter-
vention can be accomplished at the same time. For patients
in whom surgery is the only planned treatment, MRA
imaging or CTA provide excellent noninvasive alternatives
to DSA. The decision of which modality to use is mostlydriven by physician preference and local availability/exper-
tise with either CTA or MRA. The Table includes a sum-
mary of the advantages and disadvantages of the three
imaging modalities.
Patients with renal dysfunction present a difficult chal-
lenge because MRA is contraindicated due to concerns
about NSF and CTA exposes them to a significantly larger
volume of contrast than DSA. Some centers have reported
excellent results with preoperative duplex ultrasonography
either as a stand-alone imaging modality52,53 or as an
adjunct to contrast arteriography, in which duplex imaging
can identify areas of significant stenosis limiting the con-
trast arteriogram to a specific area requiring treatment. In
our practice, we prefer DSA in these patients using strate-
gies to limit contrast exposure including the use of non-
ionic iso-osmolar contrast diluted to 50% strength, using
CO2 for proximal arteries or avoiding aortoiliac imaging
altogether. All patients are hydrated with normal saline
solution or sodium bicarbonate and receive acetylcysteine
premedication as previously described.
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